Filing Details

Accession Number:
0001104659-19-027602
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-07 20:33:28
Reporting Period:
2019-05-03
Accepted Time:
2019-05-07 20:33:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421339 R. Richard Deluca Merck &Amp; Co., Inc.
2000 Galloping Hill Road
Kenilworth NJ 07033
Evp&Pres, Merck Animal Heallth No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-03 35,000 $39.29 106,064 No 4 M Direct
Common Stock Disposition 2019-05-03 35,000 $80.00 71,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2019-05-03 56,454 $0.00 56,454 $80.00
Common Stock Stock Option (right to buy) Disposition 2019-05-03 35,000 $0.00 35,000 $39.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,454 2020-05-03 2029-05-02 No 4 A Direct
38,126 2013-05-02 2022-05-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock - 401(K) Plan 1,074 Indirect By 401(k)
Footnotes
  1. Holdings include shares acquired in dividend reinvestment transactions.
  2. Includes shares acquired and dividends earned through April 5, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
  3. The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
  4. The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.